While immunosenescence features are also present in iCAD patients, they appear to be more pronounced in ASCAD, where severer lymphopenia, loss of regulatory T cells, and the accumulation of cytotoxic T and NK cells (CD28null, CD57+) define a more severe immune dysfunction. This evidence concerns the gene B3GAT1 and lymphopenia.